Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis.

de Jong CGHM, Gabius HJ, Baron W.

Cell Mol Life Sci. 2019 Oct 18. doi: 10.1007/s00018-019-03327-7. [Epub ahead of print] Review.

PMID:
31628495
2.

Diagnosis of asthma in children: the contribution of a detailed history and test results.

de Jong CCM, Pedersen ESL, Mozùn R, Goutaki M, Trachsel D, Barben J, Kuehni CE.

Eur Respir J. 2019 Sep 12. pii: 1901326. doi: 10.1183/13993003.01326-2019. [Epub ahead of print]

PMID:
31515409
3.

Addressing selection bias in diagnostic accuracy studies.

Pedersen ES, de Jong CC.

Pediatr Int. 2019 Aug;61(8):840. doi: 10.1111/ped.13860. No abstract available.

PMID:
31464055
4.

Effects and acceptability of implementing improved cookstoves and heaters to reduce household air pollution: a FRESH AIR study.

van Gemert F, de Jong C, Kirenga B, Musinguzi P, Buteme S, Sooronbaev T, Tabyshova A, Emilov B, Mademilov M, Le An P, Quynh NN, Dang TN, Hong LHTC, Chartier R, Brakema EA, van Boven JFM; FRESH AIR.

NPJ Prim Care Respir Med. 2019 Aug 15;29(1):32. doi: 10.1038/s41533-019-0144-8.

5.

Time of year, age class and body condition predict Hendra virus infection in Australian black flying foxes (Pteropus alecto).

Edson D, Peel AJ, Huth L, Mayer DG, Vidgen ME, McMichael L, Broos A, Melville D, Kristoffersen J, de Jong C, McLaughlin A, Field HE.

Epidemiol Infect. 2019 Jan;147:e240. doi: 10.1017/S0950268819001237.

6.

Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study.

Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen B, Sanderman R, Kocks J, Schultz K, van der Molen T.

J Clin Epidemiol. 2019 Jul 27;116:49-61. doi: 10.1016/j.jclinepi.2019.07.015. [Epub ahead of print]

7.

Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival.

Nair NU, Das A, Rogkoti VM, Fokkelman M, Marcotte R, de Jong CG, Koedoot E, Lee JS, Meilijson I, Hannenhalli S, Neel BG, de Water BV, Le Dévédec SE, Ruppin E.

Sci Rep. 2019 Jul 29;9(1):10989. doi: 10.1038/s41598-019-47440-w.

8.

Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice.

Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Sanderman R, Schultz K, Kocks J, van der Molen T.

BMJ Open. 2019 Jun 28;9(6):e025776. doi: 10.1136/bmjopen-2018-025776.

9.

A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.

Beurmanjer H, Asperslag EM, Oliemeulen L, Goudriaan AE, De Jong CAJ, Schellekens ASA, Dijkstra BAG.

Eur Addict Res. 2019;25(5):248-255. doi: 10.1159/000500807. Epub 2019 Jun 4.

PMID:
31163444
10.

Spirometric indices in primary ciliary dyskinesia: systematic review and meta-analysis.

Halbeisen FS, Jose A, de Jong C, Nyilas S, Latzin P, Kuehni CE, Goutaki M.

ERJ Open Res. 2019 May 10;5(2). pii: 00231-2018. doi: 10.1183/23120541.00231-2018. eCollection 2019 Apr. Review.

11.

Do clinical investigations predict long-term wheeze? A follow-up of pediatric respiratory outpatients.

de Jong CCM, Pedersen ES, Goutaki M, Trachsel D, Barben J, Kuehni CE.

Pediatr Pulmonol. 2019 Aug;54(8):1156-1161. doi: 10.1002/ppul.24347. Epub 2019 Apr 26.

PMID:
31026385
12.

Prevalence of cognitive impairment in patients with substance use disorder.

Bruijnen CJWH, Dijkstra BAG, Walvoort SJW, Markus W, VanDerNagel JEL, Kessels RPC, DE Jong CAJ.

Drug Alcohol Rev. 2019 May;38(4):435-442. doi: 10.1111/dar.12922. Epub 2019 Mar 27.

13.

Excellent reliability and validity of the Addiction Medicine Training Need Assessment Scale across four countries.

Pinxten WJL, Fitriana E, De Jong C, Klimas J, Tobin H, Barry T, Cullen W, Jokubonis D, Mazaliauskiene R, Iskandar S, Raya RP, Schellekens A.

J Subst Abuse Treat. 2019 Apr;99:61-66. doi: 10.1016/j.jsat.2019.01.009. Epub 2019 Jan 14.

PMID:
30797395
14.

Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey.

Kirenga BJ, de Jong C, Katagira W, Kasozi S, Mugenyi L, Boezen M, van der Molen T, Kamya MR.

BMC Public Health. 2019 Feb 22;19(1):227. doi: 10.1186/s12889-019-6562-2.

15.

[Demoralisation in alcohol-dependent patients with co-occurring psychiatric disorders].

de Weert-van Oene GH, de Jong CAJ.

Tijdschr Psychiatr. 2019;61(2):84-91. Dutch.

16.

Smartphone-Based Physical Activity Telecoaching in Chronic Obstructive Pulmonary Disease: Mixed-Methods Study on Patient Experiences and Lessons for Implementation.

Loeckx M, Rabinovich RA, Demeyer H, Louvaris Z, Tanner R, Rubio N, Frei A, De Jong C, Gimeno-Santos E, Rodrigues FM, Buttery SC, Hopkinson NS, Büsching G, Strassmann A, Serra I, Vogiatzis I, Garcia-Aymerich J, Polkey MI, Troosters T.

JMIR Mhealth Uhealth. 2018 Dec 21;6(12):e200. doi: 10.2196/mhealth.9774.

18.

Changes over time in Lithuanian schoolchildren's attitudes toward addictive behaviors: Promoting and preventing factors.

Leskauskas D, Adomaitienė V, De Jong CAJ, Vorevičiūtė B, Juknaitė R.

PLoS One. 2018 Dec 5;13(12):e0208481. doi: 10.1371/journal.pone.0208481. eCollection 2018.

19.

Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study.

Engel TGP, Slabbers L, de Jong C, Melchers WJG, Hagen F, Verweij PE, Merkus P, Meis JF; Dutch Cystic Fibrosis Fungal Collection Consortium.

J Cyst Fibros. 2019 Mar;18(2):221-226. doi: 10.1016/j.jcf.2018.11.012. Epub 2018 Dec 1.

PMID:
30514613
20.

Lung Function of Children at Three Sites of Varying Ambient Air Pollution Levels in Uganda: A Cross Sectional Comparative Study.

Kirenga BJ, Nantanda R, de Jong C, Mugenyi L, Meng Q, Aniku G, Williams S, Aanyu-Tukamuhebwa H, Kamya M, Schwander S, van der Molen T, Mohsenin V.

Int J Environ Res Public Health. 2018 Nov 26;15(12). pii: E2653. doi: 10.3390/ijerph15122653.

21.

The Swiss Paediatric Airway Cohort (SPAC).

Pedersen ESL, de Jong CCM, Ardura-Garcia C, Barben J, Casaulta C, Frey U, Jochmann A, Latzin P, Moeller A, Regamey N, Singer F, Spycher B, Sutter O, Goutaki M, Kuehni CE.

ERJ Open Res. 2018 Nov 20;4(4). pii: 00050-2018. doi: 10.1183/23120541.00050-2018. eCollection 2018 Oct.

22.

The Simple 10-Item Predicting Asthma Risk in Children Tool to Predict Childhood Asthma-An External Validation.

Pedersen ESL, Spycher BD, de Jong CCM, Halbeisen F, Ramette A, Gaillard EA, Granell R, Henderson AJ, Kuehni CE.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):943-953.e4. doi: 10.1016/j.jaip.2018.09.032. Epub 2018 Oct 9.

23.

Preview of highlighted presentations from the European Respiratory Society' clinical assembly.

Kahn N, Vanfleteren LEGW, Kaltsakas G, Andrianopoulos V, Gompelmann D, de Jong C, Herth FJF.

J Thorac Dis. 2018 Sep;10(Suppl 25):S3034-S3042. doi: 10.21037/jtd.2018.09.17. No abstract available.

24.

Predictive value of simulated SAR and temperature for changes in measured temperature after phase-amplitude steering during locoregional hyperthermia treatments.

Kok HP, Schooneveldt G, Bakker A, de Kroon-Oldenhof R, Korshuize-van Straten L, de Jong CE, Steggerda-Carvalho E, Geijsen ED, Stalpers LJA, Crezee J.

Int J Hyperthermia. 2018;35(1):330-339. doi: 10.1080/02656736.2018.1500720. Epub 2018 Oct 9.

PMID:
30300028
25.

Galectin-4, a Negative Regulator of Oligodendrocyte Differentiation, Is Persistently Present in Axons and Microglia/Macrophages in Multiple Sclerosis Lesions.

de Jong CGHM, Stancic M, Pinxterhuis TH, van Horssen J, van Dam AM, Gabius HJ, Baron W.

J Neuropathol Exp Neurol. 2018 Nov 1;77(11):1024-1038. doi: 10.1093/jnen/nly081.

PMID:
30252090
26.

The impact of HIV on the prevalence of asthma in Uganda: a general population survey.

Kirenga BJ, Mugenyi L, de Jong C, Lucian Davis J, Katagira W, van der Molen T, Kamya MR, Boezen M.

Respir Res. 2018 Sep 21;19(1):184. doi: 10.1186/s12931-018-0898-5.

27.

Clinically relevant differences in COPD health status: systematic review and triangulation.

Alma H, de Jong C, Tsiligianni I, Sanderman R, Kocks J, van der Molen T.

Eur Respir J. 2018 Sep 6;52(3). pii: 1800412. doi: 10.1183/13993003.00412-2018. Print 2018 Sep.

PMID:
30139774
28.

An Affinity-Based Probe for the Human Adenosine A2A Receptor.

Yang X, Michiels TJM, de Jong C, Soethoudt M, Dekker N, Gordon E, van der Stelt M, Heitman LH, van der Es D, IJzerman AP.

J Med Chem. 2018 Sep 13;61(17):7892-7901. doi: 10.1021/acs.jmedchem.8b00860. Epub 2018 Aug 21.

29.

Control of Allergic Rhinitis and Asthma Test with 1-week recall: Validation of paper and electronic version.

Flokstra-de Blok BMJ, Baretta HJ, Fonseca JA, van Heijst E, Kollen BJ, de Kroon J, van der Molen T, Tsiligianni I, de Jong C, Kocks JH.

Allergy. 2018 Dec;73(12):2381-2385. doi: 10.1111/all.13564. Epub 2018 Aug 13. No abstract available.

30.

[A boy with treatment-resistant psychiatric problems: X-linked adrenoleukodystrophy].

Voogd LPA, de Jong CMMJF, Thobokholt M, Wagener-Schimmel LJJC, Rutten AX.

Tijdschr Psychiatr. 2018;60(7):485-489. Dutch.

31.

Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.

Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen BJ, Sanderman R, Schultz K, Kocks JWH, Van der Molen T.

Health Qual Life Outcomes. 2018 Jun 26;16(1):130. doi: 10.1186/s12955-018-0950-7.

32.

Clomipramine Toxicity in a CYP 2D6 Poor Metabolizer Patient Who Suddenly Stopped Smoking.

de Jong C, Drubbel I, Roelfs S, Harmsze A.

J Clin Psychopharmacol. 2018 Aug;38(4):389-391. doi: 10.1097/JCP.0000000000000896. No abstract available.

PMID:
29894392
33.

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality.

Shouval R, de Jong CN, Fein J, Broers AEC, Danylesko I, Shimoni A, Reurs MR, Baars AE, van der Schaft N, Nagler A, Cornelissen JJ.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1685-1691. doi: 10.1016/j.bbmt.2018.05.005. Epub 2018 May 9.

34.

Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study.

Kirenga BJ, de Jong C, Mugenyi L, Katagira W, Muhofa A, Kamya MR, Boezen HM, van der Molen T.

Thorax. 2018 Oct;73(10):983-985. doi: 10.1136/thoraxjnl-2017-211157. Epub 2018 May 11.

PMID:
29752346
35.

Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.

Beurmanjer H, Kamal RM, de Jong CAJ, Dijkstra BAG, Schellekens AFA.

CNS Drugs. 2018 May;32(5):437-442. doi: 10.1007/s40263-018-0516-6.

36.

Both moderate and severe exacerbations accelerate physical activity decline in COPD patients.

Demeyer H, Costilla-Frias M, Louvaris Z, Gimeno-Santos E, Tabberer M, Rabinovich RA, de Jong C, Polkey MI, Hopkinson NS, Karlsson N, Serra I, Vogiatzis I, Troosters T, Garcia-Aymerich J; PROactive Consortium.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702110. doi: 10.1183/13993003.02110-2017. Print 2018 Jan. No abstract available.

37.

Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.

Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, Lehbert N, Wingart S, Stojanovic D, Göhl O, Alma HJ, de Jong C, van der Molen T, Faller H, Schuler M.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702000. doi: 10.1183/13993003.02000-2017. Print 2018 Jan.

38.

Professionals' Use of a Multidisciplinary Communication Tool for Patients With Dementia in Primary Care.

de Jong CC, Ros WJG, van Leeuwen M, Witkamp L, Schrijvers G.

Comput Inform Nurs. 2018 Apr;36(4):193-198. doi: 10.1097/CIN.0000000000000414.

PMID:
29360700
39.

The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa.

van Gemert FA, Kirenga BJ, Gebremariam TH, Nyale G, de Jong C, van der Molen T.

Expert Rev Respir Med. 2018 Mar;12(3):227-237. doi: 10.1080/17476348.2018.1423964. Epub 2018 Jan 10. Review.

PMID:
29298106
40.

The challenge of involving elderly patients in primary care by using an electronic communication tool with their professionals: a mixed methods study.

De Jong CC, Ros WJG, Van Leeuwen M, Schrijvers G.

J Innov Health Inform. 2017 Nov 8;24(3):937. doi: 10.14236/jhi.v24i3.937.

41.

The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.

Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ.

Psychiatry Res. 2018 Jan;259:412-421. doi: 10.1016/j.psychres.2017.11.007. Epub 2017 Nov 4. Review.

PMID:
29120851
42.

Temporary hearing threshold shift in a harbor porpoise (Phocoena phocoena) after exposure to multiple airgun sounds.

Kastelein RA, Helder-Hoek L, Van de Voorde S, von Benda-Beckmann AM, Lam FA, Jansen E, de Jong CAF, Ainslie MA.

J Acoust Soc Am. 2017 Oct;142(4):2430. doi: 10.1121/1.5007720.

PMID:
29092610
43.

Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience.

De Jong CN, Saes L, Klerk CPW, Van der Klift M, Cornelissen JJ, Broers AEC.

PLoS One. 2017 Oct 26;12(10):e0187184. doi: 10.1371/journal.pone.0187184. eCollection 2017.

44.

Primary cardiac lymphoma with central nervous system relapse.

van Rooijen CR, Scholtens AM, de Jong CN, Saraber CE, van de Donk NWCJ.

Clin Case Rep. 2017 Jul 20;5(9):1454-1458. doi: 10.1002/ccr3.1094. eCollection 2017 Sep.

45.

Intellectually disabled and addicted: a call for evidence based tailor-made interventions.

Kiewik M, VanDerNagel JEL, Engels RCME, De Jong CAJ.

Addiction. 2017 Nov;112(11):2067-2068. doi: 10.1111/add.13971. Epub 2017 Sep 3. No abstract available.

PMID:
28868632
46.

Core addiction medicine competencies for doctors: An international consultation on training.

Ayu AP, El-Guebaly N, Schellekens A, De Jong C, Welle-Strand G, Small W, Wood E, Cullen W, Klimas J.

Subst Abus. 2017 Oct-Dec;38(4):483-487. doi: 10.1080/08897077.2017.1355868. Epub 2017 Jul 18.

47.

Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman.

de Jong C, Sanders S, Creemers GJ, Burylo AM, Taks M, Schellens JHM, Deenen MJ.

Br J Clin Pharmacol. 2017 Sep;83(9):2120-2122. doi: 10.1111/bcp.13309. Epub 2017 May 31.

48.

Using the Pictorial Representation of Illness and Self Measure (PRISM) to Quantify and Compare Suffering From Trauma and Addiction.

Kok T, De Haan HA, Sensky T, van der Meer M, De Jong CAJ.

J Dual Diagn. 2017 Apr-Jun;13(2):101-108. doi: 10.1080/15504263.2017.1293867. Epub 2017 Feb 22.

PMID:
28368709
49.

Child-Robot Interactions for Second Language Tutoring to Preschool Children.

Vogt P, de Haas M, de Jong C, Baxter P, Krahmer E.

Front Hum Neurosci. 2017 Mar 2;11:73. doi: 10.3389/fnhum.2017.00073. eCollection 2017.

50.

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial.

Demeyer H, Louvaris Z, Frei A, Rabinovich RA, de Jong C, Gimeno-Santos E, Loeckx M, Buttery SC, Rubio N, Van der Molen T, Hopkinson NS, Vogiatzis I, Puhan MA, Garcia-Aymerich J, Polkey MI, Troosters T; Mr Papp PROactive study group and the PROactive consortium.

Thorax. 2017 May;72(5):415-423. doi: 10.1136/thoraxjnl-2016-209026. Epub 2017 Jan 30.

Supplemental Content

Loading ...
Support Center